This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Aventis Pharma S.a.. Active years: 2002-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2009
Title: Nathalie Bamas-Jacques: A Pioneer in Pharmaceutical Innovations
Introduction
Nathalie Bamas-Jacques is a distinguished inventor based in Paris, France. She has made significant contributions to the field of pharmaceuticals with her innovative research and development efforts. With three patents to her name, her work focuses on enhancing the effectiveness of antibiotic compounds.
Latest Patents
Bamas-Jacques’s latest patents showcase her pioneering spirit and dedication to solving complex biological challenges. One of her notable inventions pertains to novel variants of the PapM polypeptide from specific bacteria. These variants exhibit improved substrate selectivity and effectiveness compared to the wild-type polypeptide. Additionally, her patents include methods for producing B components of Streptogramins, highlighting her focus on antibiotic development. Furthermore, she has patented a method for preparing streptogramins through mutasynthesis, utilizing mutated microorganisms to enhance the biosynthesis of precursors for these compounds.
Career Highlights
Currently, Nathalie Bamas-Jacques works at Aventis Pharma S.A., where she continues to drive research and innovation within the pharmaceutical sector. Her role involves both theoretical research and practical application, allowing her to translate scientific discoveries into real-world medical solutions.
Collaborations
Throughout her career, Bamas-Jacques has collaborated with notable coworkers, including Denis Thibaut and Alain Famechon. These partnerships have fostered a productive environment for ideation and development in their shared pursuit of pharmaceutical advancements.
Conclusion
Nathalie Bamas-Jacques exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions, underscored by her patent portfolio, demonstrate her commitment to improving healthcare through scientific discovery. As she continues her work at Aventis Pharma S.A., her ongoing research is poised to have a lasting impact on the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile